camus pharma pvt develops and manufactures medicines, including formulations and active pharmaceutical ingredients (API). Their core segments include asthma, COPD, tuberculosis, ARV, oncology, anti-biotic, and biotech products. Camus Pharma reached a turnover milestone of USD 40 million in 2015 and plans to expand into regulated markets in the near future. Their target market includes pharmaceutical projects and pharmaceutical raw materials supplies.
Basic Information
Key Executives
Purchase this report to view the information.
Promoter Director
Purchase this report to view the information.
Promoter Director
Subsidiaries
Camus Builders Private Limited
99.99%
Chemerix Biotech Private Limited
99.58%
Chemerix Life Sciences Private Limited
90%
Company Performance
Financial values in the chart are available after Camus Pharma Private Limited report is purchased.
Looking for more than just a company report?
EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.
Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency INR. Absolute financial data is included in the purchased report.
Total operating revenue
-4.37%▼
Operating Profit/Loss (EBIT)
-79.86%▼
Net Profit/Loss for the Period
-81.86%▼
Operating Profit Margin (ROS)
-9.98%▼
Net Profit Margin
-8.93%▼
Return on Equity (ROE)
-16.34%▼
